News

Nateglinide acutely decreased postprandial 120 min FFA concentrations and 240 min ADMA levels more significantly than acarbose. ... Metabolism 2002; 51: 843–6.
Objective: The purpose of this study was to evaluate the metabolic effectiveness, safety, and tolerability of nateglinide in subjects with impaired glucose tolerance (IGT) and to identify a dose ...
Nateglinide and repaglinide are two newer category of agents that can act in a very similar manner to the sulfonylureas drugs. Their benefit, or their advantage, is that they act for a much ...
Table 1 reports the baseline characteristics of the study population. There were no differences among treatment groups in demographics or in metabolic indexes (HbA 1c, FPG, and fructosamine ...
Nateglinide is an antidiabetic agent, prescribed for type 2 diabetes. It lowers blood sugar level by speeding up the release of insulin from the pancreas. It is used along with diet and exercise.
Nateglinide is based on the brand-name drug Starlix, which is no longer available. Generics generally tend to cost less than brand-name drugs. How can I lower my long-term drug costs?
After a median of five years of follow-up, 36% of the nateglinide group had been diagnosed with type 2 diabetes, compared to 34% of the placebo group, a 7% relative increase. There was also no ...